169 related articles for article (PubMed ID: 22018461)
1. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
[TBL] [Abstract][Full Text] [Related]
2. Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
Gillooly KM; Pattoli MA; Taylor TL; Chen L; Cheng L; Gregor KR; Whitney GS; Susulic V; Watterson SH; Kempson J; Pitts WJ; Booth-Lute H; Yang G; Davies P; Kukral DW; Strnad J; McIntyre KW; Darienzo CJ; Salter-Cid L; Yang Z; Wang-Iverson DB; Burke JR
J Pharmacol Exp Ther; 2009 Nov; 331(2):349-60. PubMed ID: 19652024
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
Kempson J; Guo J; Das J; Moquin RV; Spergel SH; Watterson SH; Langevine CM; Dyckman AJ; Pattoli M; Burke JR; Yang X; Gillooly KM; McIntyre KW; Chen L; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
Bioorg Med Chem Lett; 2009 May; 19(10):2646-9. PubMed ID: 19376699
[TBL] [Abstract][Full Text] [Related]
5. Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors.
Kim S; Jung JK; Lee HS; Kim Y; Kim J; Choi K; Baek DJ; Moon B; Oh KS; Lee BH; Shin KJ; Pae AN; Nam G; Roh EJ; Cho YS; Choo H
Bioorg Med Chem Lett; 2011 May; 21(10):3002-6. PubMed ID: 21489792
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
Mallams AK; Rossman RR; Doll RJ; Girijavallabhan VM; Ganguly AK; Petrin J; Wang L; Patton R; Bishop WR; Carr DM; Kirschmeier P; Catino JJ; Bryant MS; Chen KJ; Korfmacher WA; Nardo C; Wang S; Nomeir AA; Lin CC; Li Z; Chen J; Lee S; Dell J; Lipari P; Liu M
J Med Chem; 1998 Mar; 41(6):877-93. PubMed ID: 9526562
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors.
Tsukada T; Takahashi M; Takemoto T; Kanno O; Yamane T; Kawamura S; Nishi T
Bioorg Med Chem Lett; 2009 Oct; 19(20):5909-12. PubMed ID: 19762234
[TBL] [Abstract][Full Text] [Related]
10. Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis.
Dyckman AJ; Langevine CM; Quesnelle C; Kempson J; Guo J; Gill P; Spergel SH; Watterson SH; Li T; Nirschl DS; Gillooly KM; Pattoli MA; McIntyre KW; Chen L; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):383-6. PubMed ID: 21087862
[TBL] [Abstract][Full Text] [Related]
11. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.
Napier SE; Letourneau JJ; Ansari N; Auld DS; Baker J; Best S; Campbell-Wan L; Chan R; Craighead M; Desai H; Ho KK; MacSweeney C; Milne R; Richard Morphy J; Neagu I; Ohlmeyer MH; Pick J; Presland J; Riviello C; Zanetakos HA; Zhao J; Webb ML
Bioorg Med Chem Lett; 2011 Jun; 21(12):3813-7. PubMed ID: 21596563
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel tricyclic class of potent and selective FIXa inhibitors.
Meng D; Andre P; Bateman TJ; Berger R; Chen YH; Desai K; Dewnani S; Ellsworth K; Feng D; Geissler WM; Guo L; Hruza A; Jian T; Li H; Metzger J; Parker DL; Reichert P; Sherer EC; Smith CJ; Sonatore LM; Tschirret-Guth R; Wu J; Xu J; Zhang T; Campeau LC; Orr R; Poirier M; McCabe-Dunn J; Araki K; Nishimura T; Sakurada I; Hirabayashi T; Wood HB
Bioorg Med Chem Lett; 2015 Nov; 25(22):5437-43. PubMed ID: 26318999
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor.
Chambers LJ; Stevens AJ; Moses AP; Michel AD; Walter DS; Davies DJ; Livermore DG; Fonfria E; Demont EH; Vimal M; Theobald PJ; Beswick PJ; Gleave RJ; Roman SA; Senger S
Bioorg Med Chem Lett; 2010 May; 20(10):3161-4. PubMed ID: 20399651
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases.
Oka Y; Yabuuchi T; Oi T; Kuroda S; Fujii Y; Ohtake H; Inoue T; Wakahara S; Kimura K; Fujita K; Endo M; Taguchi K; Sekiguchi Y
Bioorg Med Chem; 2013 Dec; 21(24):7578-83. PubMed ID: 24262886
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
[TBL] [Abstract][Full Text] [Related]
18. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA
Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179
[TBL] [Abstract][Full Text] [Related]
19. Novel tricyclic inhibitors of IkappaB kinase.
Kempson J; Spergel SH; Guo J; Quesnelle C; Gill P; Belanger D; Dyckman AJ; Li T; Watterson SH; Langevine CM; Das J; Moquin RV; Furch JA; Marinier A; Dodier M; Martel A; Nirschl D; Van Kirk K; Burke JR; Pattoli MA; Gillooly K; McIntyre KW; Chen L; Yang Z; Marathe PH; Wang-Iverson D; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
J Med Chem; 2009 Apr; 52(7):1994-2005. PubMed ID: 19267461
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects.
Wang T; Yin Z; Zhang Z; Bender JA; Yang Z; Johnson G; Yang Z; Zadjura LM; D'Arienzo CJ; DiGiugno Parker D; Gesenberg C; Yamanaka GA; Gong YF; Ho HT; Fang H; Zhou N; McAuliffe BV; Eggers BJ; Fan L; Nowicka-Sans B; Dicker IB; Gao Q; Colonno RJ; Lin PF; Meanwell NA; Kadow JF
J Med Chem; 2009 Dec; 52(23):7778-87. PubMed ID: 19769332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
